STRO - Sutro Biopharma - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

STRO is currently covered by 4 analysts with an average potential upside of $9.65 (137.18%) backed by displayed 10 price targets and 18 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 31.55% with an average time for these price targets to be met of 151.86 days.

Highest price target for STRO is 11, Lowest price target is 2, average price target is 6.5.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 15-Nov-2023. First documented stock forecast 29-Apr-2019.

Currently, out of the existing stock ratings of STRO - 11 which are a Buy (100%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

12

$9.69 (419.48%)

15 days ago

1/4 (25%)

$8.26 (128.34%)

28

Buy

12

$9.69 (419.48%)

1 months 7 days ago

0/1 (0%)

$9.05 (306.78%)

Buy

2 months 24 days ago

2/3 (66.67%)

$7.35 (40.59%)

172

Buy

17

$13.81 (432.92%)

17

3 months 16 days ago

1/8 (12.5%)

$10.04 (175.42%)

24

Buy

16

$12.81 (401.57%)

16

3 months 19 days ago

1/6 (16.67%)

$11.51 (171.26%)

568

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is STRO (Sutro Biopharma) average time for price targets to be met?

On average it took 151.86 days on average for the stock forecasts to be realized with a an average price target met ratio 31.55

Which analyst has the current highest performing score on STRO (Sutro Biopharma) with a proven track record?

KONSTANTINOS APRILAKIS

Which analyst has the current lower performing score on STRO (Sutro Biopharma) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on STRO (Sutro Biopharma)?

Konstantinos Aprilakis has 10 price targets and 10 ratings on STRO

Which analyst is the currently most bullish on STRO (Sutro Biopharma)?

Zhiqiang Shu with highest potential upside - $26.81

Which analyst is the currently most reserved on STRO (Sutro Biopharma)?

Asthika Goonewardene with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart